Detalhe da pesquisa
1.
Infusion parameters of 20% subcutaneous immunoglobulin for primary immunodeficiency diseases among patient support program participants.
Ann Allergy Asthma Immunol
; 127(5): 568-574.e1, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34224864
2.
Antigen-Specific Th17 Cells Are Primed by Distinct and Complementary Dendritic Cell Subsets in Oropharyngeal Candidiasis.
PLoS Pathog
; 11(10): e1005164, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26431538
3.
Cutting edge: IL-17-secreting innate lymphoid cells are essential for host defense against fungal infection.
J Immunol
; 190(2): 521-5, 2013 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-23255360
4.
A novel Th cell epitope of Candida albicans mediates protection from fungal infection.
J Immunol
; 188(11): 5636-43, 2012 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22529294
5.
Real-World Use, Safety, and Patient Experience of 20% Subcutaneous Immunoglobulin for Primary Immunodeficiency Diseases.
Adv Ther
; 40(12): 5168-5187, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37751025
6.
Development of a primary care screening algorithm for the early detection of patients at risk of primary antibody deficiency.
Allergy Asthma Clin Immunol
; 19(1): 44, 2023 May 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-37245042
7.
Transitioning subcutaneous immunoglobulin 20% therapies in patients with primary and secondary immunodeficiencies: Canadian real-world study.
Allergy Asthma Clin Immunol
; 18(1): 70, 2022 Aug 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35934726
8.
Innate lymphoid cells: new players in IL-17-mediated antifungal immunity.
PLoS Pathog
; 9(12): e1003763, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-24348243
9.
Correction: Transitioning subcutaneous immunoglobulin 20% therapies in patients with primary and secondary immunodeficiencies: Canadian realworld study.
Allergy Asthma Clin Immunol
; 19(1): 54, 2023 Jun 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-37353830